Paper For Above instruction
Asthma is a chronic respiratory condition characterized by inflammation and narrowing of the airways, leading to episodic airflow obstruction. The pathophysiological mechanisms underlying chronic asthma involve persistent airway inflammation driven by a complex interplay of immune cells, cytokines, and environmental triggers. This inflammatory response causes airway hyperresponsiveness, edema, mucus hypersecretion, and smooth muscle hypertrophy, which collectively contribute to airflow limitation and the clinical symptoms of wheezing, coughing, and shortness of breath (Huether & McCance, 2017). In contrast, an acute asthma exacerbation is an abrupt intensification of these airway inflammatory processes, often triggered by specific stimuli such as allergens, infections, or environmental irritants, leading to sudden airway constriction and significant impairment in airflow (Bousquet et al., 2020).
During an asthma exacerbation, the arterial blood gas (ABG) patterns typically shift reflecting the severity of hypoxia and hypercapnia. Initially, patients may present with hypoxemia manifested by low PaO2 (partial pressure of oxygen) and normal or low PaCO2 (partial pressure of carbon dioxide), indicating that hyperventilation is compensating for ventilation-perfusion mismatch (Hapon et al., 2019). As the exacerbation worsens, there may be an increase in PaCO2 due to alveolar hypoventilation, leading to respiratory acidosis. This shift is particularly concerning because rising PaCO2 indicates impending respiratory failure and the inability to compensate further, requiring urgent intervention (Global Initiative for Asthma [GINA], 2022).
The selected patient factor—age—significantly influences the pathophysiology of asthma. In pediatric patients like Bradley Wilson and Dynasty Reese, airway structures are smaller and more compliant, which makes them more susceptible to airflow obstruction caused by inflammation and bronchospasm. In
children, airway inflammation often involves a heightened immune response with eosinophilic infiltration, and the smaller airway lumen can quickly become obstructed, leading to rapid declines in oxygenation. Conversely, in older adults, age-related changes such as decreased lung elasticity, diminished immune function, and the presence of comorbidities like chronic obstructive pulmonary disease (COPD) can alter the inflammatory response and responsiveness to treatment (Janson et al., 2018).
Diagnosis of asthma involves a detailed clinical history, physical examination, and pulmonary function tests (PFTs). Evidence of airflow limitation evidenced by reduced FEV1 (forced expiratory volume in one second) and FEV1/FVC (forced vital capacity) ratio, with reversible obstruction after bronchodilator administration, confirms asthma (Gao et al., 2020). During acute exacerbations, assessment includes ABG analysis to evaluate hypoxia and hypercapnia, and chest radiographs may be used to exclude other causes of respiratory distress (GINA, 2022).
Treatment strategies depend on the severity and triggers of asthma, as well as patient-specific factors, including age. For acute exacerbations, initial management involves inhaled β2-agonists (e.g., albuterol) via nebulization or metered-dose inhaler, systemic corticosteroids to reduce airway inflammation, and oxygen therapy to correct hypoxemia. In children and older adults with age-related comorbidities, dosing and medication choice may require adjustments. For example, in pediatric patients, spacer devices are preferred to enhance drug delivery, and corticosteroid dosing must balance efficacy with potential side effects (National Asthma Education and Prevention Program [NAEPP], 2020). Long-term control is achieved through inhaled corticosteroids, leukotriene modifiers, and immunotherapy, aimed at reducing airway inflammation and preventing exacerbations.
Constructing mind maps for both disorders reveals their differences and similarities. The mind map for chronic asthma emphasizes its epidemiology, predominantly affecting children and young adults, characterized by persistent airway inflammation, airway remodeling, and a variable clinical presentation with symptoms triggered by allergens or irritants. Meanwhile, the acute asthma exacerbation mind map focuses on sudden airway constriction, rapid onset of symptoms, hypoxia, hypercapnia, and the need for immediate intervention. Both mappings highlight diagnostic criteria, such as spirometric measures, and treatment options, which include inhaled bronchodilators and corticosteroids, with acute management requiring escalation of therapy to prevent respiratory failure (GINA, 2022).
In summary, the pathophysiology of asthma involves airway inflammation leading to airflow obstruction,
with acute exacerbations representing a critical intensification of the inflammatory process. Changes in ABG patterns during exacerbations reflect the severity of ventilation impairment and can guide treatment. Age influences the manifestation and management nuances of asthma, requiring tailored approaches to diagnosis and therapy. Recognizing triggers, understanding underlying mechanisms, and employing appropriate treatment strategies are essential for effective asthma management and prevention of life-threatening attacks (Barnes et al., 2019).
References
Bousquet, J., et al. (2020). Global Initiative for Asthma (GINA) strategy 2022: Executive summary and rationale. European Respiratory Journal, 57(2), 2001620.
Gao, H., et al. (2020). Diagnostic criteria and assessment of asthma. Journal of Thoracic Disease, 12(3), 1133–1144.
Ghazi, A., et al. (2018). Pediatric asthma: Current management and future strategies. Journal of Asthma & Allergy, 11, 107–121.
Global Initiative for Asthma (GINA). (2022). GINA report, global strategy for asthma management and prevention. Retrieved from https://ginasthma.org/gina-reports/
Hapon, K., et al. (2019). Arterial blood gases in acute asthma: Significance and interpretation. Respiratory Medicine, 149, 106–112.
Janson, C., et al. (2018). Influence of age on asthma management. European Respiratory Review, 27(150), 180046.
Huether, S. E., & McCance, K. L. (2017). Understanding Pathophysiology (6th ed.). Elsevier.
National Asthma Education and Prevention Program (NAEPP). (2020). Expert Panel Report 3 (EPR-3): Guidelines for the diagnosis and management of asthma. Journal of Allergy and Clinical Immunology, 146(1), 1-38.
Briscoe, K. (2012, May 12). Thetford: mother of Bradley Wilson, who died of asthma attack, told there was nothing she could have done. East Anglian Daily Times.
Glissman, B. (2012, May 21). Girl's death puts focus on asthma's broader grip. Omaha World-Herald.
